Transmission of human herpesvirus 8: An update

Current Opinion in Infectious Diseases

Volumn 20, Issue 2, 2007, Pages 152-156

  Pica, Francesca ^a   Volpi, Antonio ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Blood transfusion; Human herpesvirus 8; Transmission; Transplantation; Vertical

Indexed keywords

RAPAMYCIN;

BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; CYTOMEGALOVIRUS; DISEASE TRANSMISSION; ENVIRONMENTAL EXPOSURE; EPSTEIN BARR VIRUS; GRAFT RECIPIENT; HEART TRANSPLANTATION; HEMODIALYSIS; HERPES SIMPLEX; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; IMMUNOCOMPETENCE; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ABUSE; KAPOSI SARCOMA; KIDNEY PANCREAS TRANSPLANTATION; KIDNEY TRANSPLANTATION; LABORATORY DIAGNOSIS; LIVER TRANSPLANTATION; NONHUMAN; PLACENTAL TRANSFER; REVIEW; SALIVA; SEROLOGY; SEXUALLY TRANSMITTED DISEASE; VERTICAL TRANSMISSION; VIRAL CONTAMINATION; VIRUS CELL INTERACTION; VIRUS REACTIVATION; VIRUS SHEDDING; VIRUS TRANSMISSION;

DISEASE TRANSMISSION, VERTICAL; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; IMMUNOCOMPROMISED HOST; MALE; PREGNANCY; TRANSPLANTS;

EID: 33847422259     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/QCO.0b013e3280143919     Document Type: Review

References (50)

1. Henke-Gendo C, Schulz TF. Transmission and disease association of Kaposi's sarcoma-associated herpesvirus: recent developments. Curr Opin Infect Dis 2004; 17:53-57.
2. Calabrò ML, Fiore JR, Favero A, et al. Detection of human herpesvirus 8 in cervicovaginal secretions and seroprevalence in immunodeficiency virus type 1-seropositive and -seronegative women. J Infect Dis 1999; 179:1534-1537.
3. Calabrò ML, Gasperini P, Barbierato M, et al. A search for human herpesvirus 8 (HHV-8) in HIV-1 infected mothers and their infants does not suggest vertical transmission of HHV-8. Int J Cancer 2000; 85:296-297.
4. Gessain A, Mauclere P, Van Beveren M, et al. Human herpesvirus 8 primary infection occurs during childhood in Cameroon, Central Africa. Int J Cancer 1999; 81:189-192.
5. Gutierrez-Ortega P, Hierro-Orozco S, Sanchez-Cisneros R, Montano LF. Kaposi's sarcoma in a 6-day-old infant with human immunodeficiency virus. Arch Dermatol 1989; 125:432-433.
6. Brayfield BP, Phiri S, Kankasa C, et al. Postnatal human herpesvirus 8 and human immunodeficiency virus type 1 infection in mothers and infants from Zambia. J Infect Dis 2003; 187:559-568.
7. Lisco A, Barbierato M, Fiore JR, et al. Pregnancy and human herpesvirus 8 reactivation in human immunodeficiency virus type 1-infected women. J Clin Microbiol 2006; 44:3863-3871. This paper documents vertical transmission of HHV-8.
8. Gaye-Diallo A, Toure AT, Gessain A, et al. Preliminary study of human Herpesvirus type 8 infection in pregnant women in Dakar (Senegal). Bull Soc Pathol Exot 2001; 94:231-234.
9. Sarmati L, Ticconi C, Santangelo R, et al. Does the risk of abortion increase in women with high human herpesvirus 8 antibody titers? J Infect Dis 2003; 188:173-174.
10. Dedicoat M, Newton R, Alkharsah KR, et al. Mother-to-child transmission of human herpesvirus-8 in South Africa. J Infect Dis 2004; 190:1068-1075.
11. Mbulaiteye SM, Marshall V, Bagni RK, et al. Molecular evidence for motherto-child transmission of Kaposi Sarcoma-associated Herpesvirus in Uganda and K1 gene evolution within the host. J Infect Dis 2006; 193:1250-1257. Evidence of transmission from maternal and non-maternal sources in a HHV-8 endemic region.
12. Mbulaiteye SM, Pfeiffer RM, Engels EA, et al. Detection of Kaposi sarcoma-associated herpesvirus DNA in saliva and buffy-coat samples from children with sickle cell disease in Uganda. J Infect Dis 2004; 190:1382-1386.
13. Pass RF, Hutto C, Ricks R, Cloud GA. Increased rate of cytomegalovirus infection among parents of children attending day-care centers. N Engl J Med 1986; 314:1414-1418.
14. Volpi A, Pica F, Cauletti M, et al. Cytomegalovirus infection in day care centers in Rome, Italy: viral excretion in children and occupational risk among workers. J Med Virol 1988; 26:119-125.
15. Suligoi B, Danaya RT, Sarmati L, et al. Infection with human immunodeficiency virus, herpes simplex virus type 2, and human herpesvirus 8 in remote villages of southwestern Papua New Guinea. Am J Trop Med Hyg 2005; 72:33-36.
16. Cunha AMG, Caterino-de-Araujo A, Costa SCB, et al. Increasing seroprevalence of human herpesvirus 8 (HHV-8) with age confirms HHV-8 endemicity in Amazon Amerindians from Brazil. J Gen Virol 2005; 86:2433-2437.
17. Kazanji M, Dussart P, Duprez R, et al. Serological and molecular evidence that human herpesvirus 8 is endemic among Amerindians in French Guiana. J Infect Dis 2005; 192:1525-1529.
18. Olsen S, Chang Y, Moore PS, et al. Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985. AIDS 1998; 12:1921-1925.
19. Mbulaiteye SM, Biggar RJ, Pfeiffer RM, et al. Water, socioeconomic factors, and human herpesvirus 8 infection in Ugandan children and their mothers. J Acquir Immune Defic Syndr 2005; 38:474-479.
20. Baillargeon J, Leach CT, Deng JH, et al. High prevalence of human herpesvirus 8 (HHV-8) infection in south Texas children. J Med Virol 2002; 67:542-548.
21. Martro E, Bulterys M, Stewart JA, et al. Comparison of human herpesvirus 8 and Epstein-Barr virus seropositivity among children in areas endemic and nonendemic for Kaposi's sarcoma. J Med Virol 2004; 72:126-131.
22. Ramos S, Lukefahr JL, Morrow RA, et al. Prevalence of herpes simplex virus types 1 and 2 among children and adolescents attending a sexual abuse clinic. Pediatr Infect Dis J 2006; 25:902-905.
23. Edelman DC. Human herpesvirus 8 - a novel human pathogen. Virol J 2005; 2:78.
24. Miller CS, Berger JR, Mootoor Y, et al. High prevalence of multiple human herpesvirus in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy. J Clin Microbiol 2006; 44:2409-2415. Direct relationship between CD4 cell count and probability of having HHV-8 in saliva in HIV-infected patients.
25. Widmer IC, Erb P, Grob H, et al. Human herpesvirus 8 oral shedding in HIV-infected men with and without Kaposi's sarcoma. J Acquir Immune Defic Syndr 2006; 42:420-425.
26. Casper C, Carrel D, Miller KG, et al. HIV serodiscordant sex partners and the prevalence of human herpesvirus 8 infection among HIV negative men who have sex with men: baseline data from the EXPLORE Study. Sex Transm Infect 2006; 82:229-235. Saliva can be the main source of transmission even in HIV-negative MSM.
27. Mbulaiteye SM, Walters M, Engels EA, et al. High levels of Epstein-Barr virus DNA in saliva and peripheral blood from Ugandan mother-child pairs. J Infect Dis 2006; 193:422-426.
28. Bagasra O, Patel D, Bobroski L, et al. Localization of human herpesvirus type 8 in human sperms by in situ PCR. J Mol Histol 2005; 36:401-412.
29. Mbulaiteye SM, Atkinson JO, Whitby D, et al. Risk factors for human herpesvirus 8 seropositivity in the AIDS Cancer Cohort Study. J Clin Virol 2006; 35:442-449.
30. Volpi A, Sarmati L, Suligoi B, et al. Correlates of human herpesvirus-8 and herpes simplex type 2 infections in Northern Cameroon. J Med Virol 2004; 74:467-472.
31. Casper C, Meier AS, Wald A, et al. Human herpesvirus 8 infection among adolescents in the REACH Cohort. Arch Pediatr Adolesc Med 2006; 160:937-942. HIV-positive adolescent MSM appear to acquire HIV prior to HHV-8, which is clinically relevant since it has been shown that HHV-8 seroconversion during HIV infection is highly predictive of Kaposi's sarcoma, but not the opposite.
32. Duus KM, Lentchitsky V, Wagenaar T, et al. Wild-type Kaposi's sarcoma-associated herpesvirus isolated from the oropharynx of immune-competent individuals has tropism for cultured oral epithelial cells. J Virol 2004; 78:4074-4084.
33. Guttman-Yassky E, Kra-Os Z, Dubnov J, et al. Infection with Kaposi's sarcoma-associated herpesvirus among families of patients with classic Kaposi's sarcoma. Arch Dermatol 2005; 141:1429-1434.
34. Marcelin AG, Gorin I, Morand P, et al. Quantification of Kaposi's sarcoma-associated herpesvirus in blood, oral mucosa, and saliva in patients with Kaposi's sarcoma. AIDS Res Hum Retroviruses 2004; 20:704-708.
35. Chagas CA, Endo LH, Dos-Santos WLC, et al. Is there a relationship between the detection of human herpesvirus 8 and Epstein-Barr virus in Waldeyer's ring tissues? Int J Pediatr Otorhinolaryngol 2006; 11:1923-1927.
36. Dodd RY. Human herpesvirus-8: what to do? Transfusion 2005; 45:463-465.
37. Dollard SC, Nelson KE, Ness PM, et al. Possible transmission of human herpesvirus-8 by blood transfusion in a historical United States cohort. Transfusion 2005; 45:500-503.
38. Hladik W, Dollard SC, Mermin J, et al. Transmission of human herpesvirus 8 by blood transfusion. N Engl J Med 2006; 355:1331-1338. This excellent study presents important evidence on acquisition of HHV-8 by blood transfusion.
39. Zavitsanou A, Sypsa V, Petrodaskalaki M, et al. Human herpesvirus infection in hemodialysis patients. Am J Kidney Dis 2006; 47:167-170.
40. Laney AS, Peters JS, Manzi SM, et al. Use of a multiantigen detection algorithm for diagnosis of Kaposi's sarcoma-associated herpesvirus infection. J Clin Microbiol 2006; 44:3734-3741. This paper proposes a systematic approach to optimize and standardize serological methods for the assessment of HHV-8 infection.
41. Dantal J, Soulillou JP. Immunosuppressive drugs and the risk of cancer after organ transplantation. N Engl J Med 2005; 352:1371-1373.
42. Razonable RR, Brown RA, Humar A, et al. Herpesvirus infections in solid organ transplant patients at high risk of primary cytomegalovirus disease. J Infect Dis 2005; 192:1331-1339.
43. Becuwe C, Euvrard S, Bsshard S, et al. Kaposi's sarcoma and organ transplantation: 22 cases. Ann Dermatol Venereol 2005; 132:839-843.
44. Weigert AL, Pires A, Adragao T, et al. Human herpesvirus 8 serology and DNA analysis in recipient of renal allografts showing Kaposi's sarcoma and their respective donors. Transplant Proc 2004; 36:902-904.
45. Alzaharani AJ, El-Harith el-HA, Milzer J, et al. Increased seroprevalence of human herpesvirus 8 in renal transplant recipient in Saudi Arabia. Nephrol Dial Transplant 2005; 20:2532-2536.
46. Gentile G, Capobianchi A, Volpi A, et al. Human Herpesvirus 8 DNA in serum during seroconversion in allogeneic bone marrow transplant recipient. J Natl Cancer Inst 2005; 97:1008-1011.
47. Bower M, Nelson M, Young AM, et al. Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma. J Clin Oncol 2005; 23:5224-5228.
48. Guihot A, Dupin N, Marcelin AG, et al. Low T cell responses to human herpesvirus 8 in patients with AIDS-related and classic Kaposi sarcoma. J Infect Dis 2006; 194:1078-1088. This study shows that HIV-related and classic Kaposi's sarcoma are possibly associated with a lack of HHV-8-specific T cells. The authors also identified eight new regions in three latent proteins that contain T cell epitopes. It can help to better study cellular immune response to HHV-8.
49. Brown EE, Fallin MD, Goedert JJ, et al. Host immunogenetics and control of human herpesvirus-8 infection. J Infect Dis 2006; 193:1054-1062. This study presents evidence that key host immune genes can influence the control of HHV-8 infection.
50. Casrouge A, Zhang SY, Eidenschenk C, et al. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 2006; 314:308-312.